Examkin

Question

Difficulty: MediumHematology and Oncology

A 72-year-old woman is brought to the emergency department by her family after sustaining a fall at home. Four weeks ago, she was evaluated at an urgent care clinic for progressive fatigue, a smooth, red tongue, and mild tingling in her feet. At that time, her hemoglobin was 9.2 g/dL, mean corpuscular volume was 115 fL, and a peripheral blood smear showed hypersegmented neutrophils. She was diagnosed with megaloblastic anemia and started on high-dose oral folic acid supplementation by the urgent care provider.

Today, her family reports that her fatigue has improved, but her unsteadiness and numbness have significantly worsened over the past two weeks, leading to her fall. She has a past medical history of Hashimoto thyroiditis and takes levothyroxine. She consumes a standard omnivorous diet.

Vital signs are within normal limits. Neurologic examination reveals decreased vibratory sensation and proprioception in the bilateral lower extremities. Her gait is markedly wide-based and ataxic. Romberg test is positive. Repeat laboratory studies today show a hemoglobin of 10.8 g/dL and a mean corpuscular volume of 102 fL.

Which of the following best explains the clinical course of this patient?

  1. A
    Rapid hematopoiesis induced by folic acid led to a severe intracellular potassium shift and resultant hypokalemia.
  2. B
    High-dose folic acid caused direct toxic demyelination of the posterior columns and lateral corticospinal tracts.
  3. Folic acid supplementation corrected the hematologic deficit but allowed the underlying neurologic degeneration to progress.Answer
  4. D
    The increase in red blood cell mass precipitated an acute cardiopulmonary exacerbation due to increased blood viscosity.
  5. E
    Resolution of macrocytosis unmasked a coexisting iron deficiency, leading to severe cerebral hypoxia.

Answer

The patient's clinical course is best explained by folic acid supplementation correcting the megaloblastic anemia while allowing the underlying vitamin B12 deficiency-mediated neurologic degeneration to progress.
The correct answer explains that folic acid supplementation corrects the hematologic manifestations of vitamin B12 deficiency without treating the neurologic manifestations. Vitamin B12 and folate are both required for DNA synthesis (via the conversion of homocysteine to methionine). Providing high doses of folate can bypass the B12-dependent step in this pathway, resolving the megaloblastic anemia. However, vitamin B12 is uniquely required for the conversion of methylmalonyl-CoA to succinyl-CoA, which is necessary for proper myelin synthesis. Because folate does not participate in this pathway, the demyelination of the dorsal columns and lateral corticospinal tracts (subacute combined degeneration) continues unchecked, leading to worsening sensory ataxia, loss of proprioception, and falls.

Step-by-Step Solution

1
Identify the patient's initial underlying diagnosis based on her clinical presentation and laboratory findings.
The patient initially presented with a macrocytic anemia, hypersegmented neutrophils, a smooth red tongue (glossitis), and mild neurologic symptoms (tingling). Given her history of Hashimoto thyroiditis, she most likely has pernicious anemia leading to vitamin B12 deficiency.
Establishing the true underlying diagnosis is necessary because the urgent care provider only diagnosed a generic 'megaloblastic anemia' and initiated incomplete therapy.
2
Analyze the physiological effect of the prescribed treatment (folic acid) on the patient's underlying condition.
The patient was treated with isolated folic acid. Her anemia improved (hemoglobin increased from 9.2 to 10.8 g/dL), but her neurologic symptoms significantly worsened, progressing to severe ataxia and loss of proprioception.
To connect the specific medical intervention with the divergent changes in her hematologic and neurologic status.
3
Determine the biochemical mechanism that explains this divergent clinical response.
Folate administration bypasses the metabolic block in DNA synthesis caused by B12 deficiency, successfully correcting the hematologic abnormalities. However, folate cannot replace vitamin B12 in the conversion of methylmalonyl-CoA to succinyl-CoA, a step that is crucial for myelin synthesis. Therefore, the subacute combined degeneration of the spinal cord progresses unchecked.
To explain the core pathophysiological concept of why folic acid masks vitamin B12 deficiency.

Key Concept

In a patient with vitamin B12 deficiency, inappropriate monotherapy with folic acid can correct the megaloblastic anemia but will mask and fail to halt the progression of subacute combined degeneration of the spinal cord.
Rate this question

Topics

Hematology and Oncology

More questions from this topic